HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability.

Abstract
Background Dysfunctional endothelium may contribute to the development of cardiovascular complications in chronic kidney disease ( CKD ). Supplementation with active vitamin D has been proposed to have vasoprotective potential in CKD , not only by direct effects on the endothelium but also by an increment of α-Klotho. Here, we explored the capacity of the active vitamin D analogue paricalcitol to protect against uremia-induced endothelial damage and the extent to which this was dependent on increased α-Klotho concentrations. Methods and Results In a combined rat model of CKD with vitamin D deficiency, renal failure induced vascular permeability and endothelial-gap formation in thoracic aorta irrespective of baseline vitamin D, and this was attenuated by paricalcitol. Downregulation of renal and serum α-Klotho was found in the CKD model, which was not restored by paricalcitol. By measuring the real-time changes of the human endothelial barrier function, we found that paricalcitol effectively improved the recovery of endothelial integrity following the addition of the pro-permeability factor thrombin and the induction of a wound. Furthermore, immunofluorescence staining revealed that paricalcitol promoted vascular endothelial-cadherin-based cell-cell junctions and diminished F-actin stress fiber organization, preventing the formation of endothelial intracellular gaps. Conclusions Our results demonstrate that paricalcitol attenuates the CKD -induced endothelial damage in the thoracic aorta and directly mediates endothelial stability in vitro by enforcing cell-cell interactions.
AuthorsMarc Vila Cuenca, Evelina Ferrantelli, Elisa Meinster, Stephan M Pouw, Igor Kovačević, Renee X de Menezes, Hans W Niessen, Robert H J Beelen, Peter L Hordijk, Marc G Vervloet
JournalJournal of the American Heart Association (J Am Heart Assoc) Vol. 7 Issue 17 Pg. e008776 (09 04 2018) ISSN: 2047-9980 [Electronic] England
PMID30371149 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • Cadherins
  • Ergocalciferols
  • paricalcitol
  • Glucuronidase
  • Klotho Proteins
Topics
  • Actins (drug effects, metabolism)
  • Animals
  • Aorta, Thoracic (drug effects, metabolism)
  • Cadherins (drug effects, metabolism)
  • Capillary Permeability (drug effects)
  • Disease Models, Animal
  • Endothelium, Vascular (drug effects, metabolism, physiopathology)
  • Ergocalciferols (pharmacology)
  • Glucuronidase (drug effects, metabolism)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Intercellular Junctions (drug effects, metabolism)
  • Klotho Proteins
  • Rats
  • Renal Insufficiency, Chronic (metabolism)
  • Stress Fibers (drug effects)
  • Uremia (metabolism)
  • Vitamin D Deficiency (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: